| Literature DB >> 33473239 |
Alaa Abdelqader Altaweel1,2, Abdel Aziz Baiomy Abdullah Baiomy3, Shadia Abdel-Hameed Elsayed4,5.
Abstract
OBJECTIVE: This study aimed to assess the clinical and radiographic findings obtained by using amniotic membrane (AM) to cover nano-hydroxyapatite (nHA) bone grafts coated with platelet-rich fibrin (PRF) and thereby evaluate the osseointegration of posterior mandibular implants inserted simultaneously during alveolar piezoelectric ridge splitting technique (RST).Entities:
Keywords: Implant; PRF; Piezoelectric; Ridge split
Year: 2019 PMID: 33473239 PMCID: PMC7801237 DOI: 10.1016/j.sdentj.2019.11.008
Source DB: PubMed Journal: Saudi Dent J ISSN: 1013-9052
Fig. 1Intraoperative photograph showing (A) PRF prepared and cut down for group III, (B) AM placed above the split ridge in groups II and III, and (C) nHA used in all groups.
Fig. 2Intraoperative photograph showing (A) a mid-crestal incision and piezoelectric RST in the posterior mandible, (B) an n-HA graft inserted in the created gaps, (C) suturing of the flap, and (D) the abutment fixed in place.
Fig. 3CBCT image showing (A) measurements of ridge width and bone density on a preoperative cross-sectional cut of the lower right first molar and (B) 6 months postoperative CBCT and (C) 12 months post-operative CBCT showing the bone level on both buccal and lingual cortices.
Illustrating range, mean, minimum, maximum and standard deviation of implant stability quotient (ISQ) and alveolar bone width in all groups and comparison between the two different intervals.
| Baseline Vs. 6 Month | ||||||||
|---|---|---|---|---|---|---|---|---|
| ISQ | Group I | baseline | 20 | 55 | 75 | 68.45 | ±5.22 | |
| 6 month | 21 | 50 | 71 | 64.73 | ±5.83 | |||
| Group II | baseline | 9 | 65 | 74 | 69.09 | ±2.84 | ||
| 6 month | 9 | 63 | 72 | 67.55 | ±2.46 | |||
| Group III | baseline | 10 | 65 | 75 | 69.00 | ±3.03 | ||
| 6 month | 9 | 60 | 69 | 66.55 | ±2.66 | |||
| Alveolar bone width | Group I | 1.7 | 3.3 | 5 | 3.99 | ±0.4 | ||
| 3.1 | 4.9 | 8 | 6.84 | ±1.1 | ||||
| Group II | 0.9 | 3.2 | 4.1 | 3.64 | ±0.3 | |||
| 1.9 | 6.1 | 8 | 6.90 | ±0.6 | ||||
| Group III | 1.9 | 3.1 | 5 | 4.17 | ±0.7 | |||
| 1.3 | 6.2 | 7.5 | 6.65 | ±0.4 | ||||
Statistically significant: (P < 0.05).
High statistically significant: (P < 0.01).
Illustrating range, minimum, maximum, means and standard deviations of bone density (BD) in all groups and measurements comparison during different intervals within groups.
| P | |||||||
|---|---|---|---|---|---|---|---|
| Group I | baseline | 17 | 71 | 88 | 77.91 | ±5.54 | |
| 3 month | 13 | 77 | 90 | 80.55 | ±4.97 | ||
| 6 month | 11 | 78 | 99 | 84.82 | ±6.05 | ||
| 12 month | 30 | 69 | 101 | 90.09 | ±8.92 | ||
| Group II | baseline | 19 | 70 | 89 | 80.55 | ±5.75 | |
| 3 month | 26 | 73 | 99 | 87.82 | ±7.17 | ||
| 6 month | 26 | 74 | 100 | 90.91 | ±7.98 | ||
| 12 month | 34 | 75 | 109 | 98.91 | ±9.32 | ||
| Group III | baseline | 11 | 79 | 90 | 83.91 | ±4.01 | |
| 3 month | 19 | 85 | 99 | 90.55 | ±4.97 | ||
| 6 month | 15 | 90 | 105 | 97.45 | ±4.46 | ||
| 12 month | 10 | 105 | 115 | 111.09 | ±3.45 | ||
Statistically significant: (P < 0.05).
High statistically significant: (P < 0.01).